D. Urdal

发表

Chapter 23. Cytokine Receptors

D. Urdal, 1991 .

Characterization of the cell surface receptor for human granulocyte/macrophage colony-stimulating factor

D. Friend, L. Park, S. Gillis, 1986, The Journal of experimental medicine.

Characterization of the human B cell stimulatory factor 1 receptor

D. Friend, L. Park, H. Sassenfeld, 1987, The Journal of experimental medicine.

Human macrophage-colony stimulating factor: alternative RNA and protein processing from a single gene.

D. Cerretti, D. Cosman, B. Gallis, 1988, Molecular immunology.

The interleukin-1 receptor.

S. Dower, D. Urdal, 1987, Immunology today.

Characterization of the cell surface receptor for granulocyte-macrophage colony-stimulating factor.

D. Friend, L. Park, S. Gillis, 1986, The Journal of biological chemistry.

Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor.

V. Price, K. Grabstein, P. Conlon, 1986, Science.

The cell surface receptors for interleukin-1 alpha and interleukin-1 beta are identical.

T. Hopp, S. Dower, C. Henney, 1986, Nature.

Detection and characterization of high affinity plasma membrane receptors for human interleukin 1

C. March, T. Hopp, S. Dower, 1985, The Journal of experimental medicine.

Quantitative measurement of human interleukin 2 receptor levels with intact and detergent-solubilized human T-cells.

S. Dower, S. Hefeneider, D. Urdal, 1985, Molecular immunology.

Monoclonal antibodies and immobilized antibodies

C. A. White, R. Krauss, M. Melamed, 1987 .

S. Dower, S. Gillis, D. Urdal, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Heterogeneity in human interleukin-3 receptors. A subclass that binds human granulocyte/macrophage colony stimulating factor.

D. Friend, V. Price, K. Prickett, 1989, The Journal of biological chemistry.

Expression, purification and characterization of recombinant murine granulocyte-macrophage colony-stimulating factor and bovine interleukin-2 from yeast.

C. March, V. Price, D. Cosman, 1987, Gene.

Interleukin 2 administered in vivo induces the growth of cultured T cells in vivo.

J. Thompson, P. Greenberg, M. Cheever, 1984, Journal of immunology.

Regulation of murine T cell proliferation by B cell stimulatory factor-1.

P. Morrissey, V. Price, K. Grabstein, 1987, Journal of immunology.

Synergistic interactions between interleukin-11 and interleukin-4 in support of proliferation of primitive hematopoietic progenitors of mice.

M. Ogawa, S. Clark, T. Sudo, 1991, Blood.

Murine B‐cell stimulatory factor‐1 (BSF‐1)/Interleukin‐4 (IL‐4) is a multilineage colony‐stimulating factor that acts directly on primitive hemopoietic progenitors

J. Ihle, K. Kishi, M. Ogawa, 1989, Journal of cellular physiology.

Characterization of the high-affinity cell-surface receptor for murine B-cell-stimulating factor 1.

D. Friend, K. Grabstein, L. Park, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Expression of interleukin 2, interferon-gamma, and the IL 2 receptor by human peripheral blood lymphocytes.

K. Grabstein, S. Dower, A. Larsen, 1986, Journal of immunology.

Autologous cellular immunotherapy in late-stage prostate cancer: The development history of Sipuleucel-T (PROVENGE®)

M. Frohlich, D. Urdal, 2011 .

High level stable expression of human interleukin-2 receptors in mouse cells generates only low affinity interleukin-2 binding sites.

D. Cerretti, D. Cosman, L. Park, 1986, Molecular immunology.

Selective depletion of nk cell activity in vivo and its effect on the growth of NK‐sensitive and nk‐resistant tumor cell variants

I. Kawase, C. Henney, D. Urdal, 1982, International journal of cancer.

Purification and chemical characterization of the receptor for interleukin 2 from activated human T lymphocytes and from a human T-cell lymphoma cell line.

C. March, S. Dower, A. Larsen, 1984, Proceedings of the National Academy of Sciences of the United States of America.

The mechanism of augmentation of natural killer cell activity by syngeneic tumor cells: Role of macrophage‐derived factor in NK boosting

I. Kawase, W. Newman, C. Henney, 1983, International journal of cancer.

THE EFFECT OF SELECTIVE NK CELL DEPLETION ON THE GROWTH OF NK SENSITIVE AND RESISTANT LYMPHOMA CELL VARIANTS

I. Kawase, C. Henney, D. Urdal, 1982 .

Affinity purification and chemical analysis of the interleukin-1 receptor.

S. Dower, S. Dower, D. Urdal, 1988, The Journal of biological chemistry.

Generation of anti-peptide monoclonal antibodies which recognize mature CSF-2 alpha (IL 3) protein.

C. March, T. Hopp, L. Park, 1985, Journal of immunology.

In Vivo Biologic Activities of Recombinant Human Granulocyte‐Macrophage Colony‐Stimulating Factor

J. Gutterman, W. Hittelman, H. Broxmeyer, 1989, Annals of the New York Academy of Sciences.

Lymphokine purification by reversed-phase high-performance liquid chromatography.

M. L. Remerowski, C. March, P. Conlon, 1984, Journal of chromatography.

Factors affecting expression of glycolipid tumor antigens: influence of ceramide composition and coexisting glycolipid on the antigenicity of gangliotriaosylceramide in murine lymphoma cells.

S. Hakomori, R. Kannagi, W. Young, 1983, Cancer research.

Characterization of tumor-associated ganglio-N-triaosylceramide in mouse lymphoma and the dependency of its exposure and antigenicity on the sialosyl residues of a second glycoconjugate.

S. Hakomori, D. Urdal, 1983, The Journal of biological chemistry.

A granulocyte reactive monoclonal antibody, 1G10, identifies the Gal beta 1-4 (Fuc alpha 1-3)GlcNAc (X determinant) expressed in HL-60 cells on both glycolipid and glycoprotein molecules.

I. Bernstein, S. Hakomori, D. Urdal, 1983, Blood.

Characterization of the antibodies in normal rabbit serum responsible for the lysis of NK-sensitive target cells.

C. Henney, D. Urdal, 1982, Molecular immunology.

The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor.

K. Prickett, D. Cosman, S. Dower, 1987, The Journal of biological chemistry.

The cell surface receptors for interleukin-1α and interleukin-1β are identical

T. Hopp, S. Dower, C. Henney, 1986, Nature.

Cloning, sequence and expression of human interleukin-2 receptor

C. March, S. Dower, D. Cerretti, 1984, Nature.

Glycolipid expression in lymphoma cell variants: chemical quantity, immunologic reactivity, and correlations with susceptibility to NK cells.

S. Hakomori, J. Durdik, C. Henney, 1981, Journal of immunology.

NK cell-target interactions: approaches towards definition of recognition structures

I. Kawase, C. Henney, D. Urdal, 2004, Cancer and Metastasis Reviews.

A Short Polypeptide Marker Sequence Useful for Recombinant Protein Identification and Purification

Kathryn S. Prickett, Carl J. March, C. March, 1988, Bio/Technology.

Tumor-associated ganglio-N-triosylceramide. Target for antibody-dependent, avidin-mediated drug killing of tumor cells.

S. Hakomori, D. Urdal, 1980, The Journal of biological chemistry.

Comparative effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice.

D. Williams, H. Broxmeyer, A. Waheed, 1987, The Journal of clinical investigation.

Purification to homogeneity of a human hematopoietic growth factor that stimulates the growth of a murine interleukin 3-dependent cell line.

J. Watson, C. March, P. Crosier, 1986, Journal of immunology.

Stimulation of B-cell progenitors by cloned murine interleukin-7

C. March, R. Goodwin, D. Cosman, 1988, Nature.

Expression and purification of native human granulocyte-macrophage colony-stimulating factor from an Escherichia coli secretion vector.

C. March, T. Hopp, T. Chiaverotti, 1987, DNA.

B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors

C. March, L. Park, A. Namen, 1988, The Journal of experimental medicine.

Interleukin-3, GM-CSF, and G-CSF receptor expression on cell lines and primary leukemia cells: receptor heterogeneity and relationship to growth factor responsiveness.

I. Bernstein, R. Andrews, Diana Anderson, 1989, Blood.

The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound forms

Alan I. Alpert, C. March, D. Friend, 1989, Cell.

Purification to homogeneity and partial characterization of interleukin 2 from a human T-cell leukemia.

S. Gillis, D. Urdal, R. Blacher, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Purification and Characterization of a Growth Factor Active on

L. Park, A. Namen, R. Overell, 2006 .

Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer

P. Kantoff, D. Petrylak, J. Whitmore, 2012, Cancer Immunology, Immunotherapy.

The effects of purified recombinant murine interleukin-3 and/or purified natural murine CSF-1 in vivo on the proliferation of murine high- and low-proliferative potential colony-forming cells: demonstration of in vivo synergism.

D. Williams, H. Broxmeyer, A. Waheed, 1987, Blood.

Biochemical comparison of murine colony-stimulating factors secreted by a T cell lymphoma and a myelomonocytic leukemia.

J. Watson, P. Conlon, S. Gillis, 1984, Journal of immunology.

Regulation of antibody production in vitro by granulocyte-macrophage colony stimulating factor.

V. Price, D. Cosman, K. Grabstein, 1986, The Journal of molecular and cellular immunology : JMCI.

murine recipients by granulocyte/macrophage colony-stimulating factor Augmentation of donor bone marrow engraftment in histoincompatible

B. Blazar, D. Vallera, S. Gillis, 2011 .

Augmentation of donor bone marrow engraftment in histoincompatible murine recipients by granulocyte/macrophage colony-stimulating factor.

B. Blazar, D. Vallera, L., 1988, Blood.

Lymphokine‐Driven “Differentiation” of Cytotoxic T‐Cell Clones into Cells with NK‐Like Specificity: Correlations with Display of Membrane Macromolecules

C. Henney, D. Urdal, C. Brooks, 1983, Immunological reviews.

Development and characterization of antiserum to murine granulocyte-macrophage colony-stimulating factor.

L. Park, P. Conlon, D. Urdal, 1986, Journal of immunology.

Characterization of antigen-specific T-cell activation and cytokine expression induced by sipuleucel-T.

M. Frohlich, N. Sheikh, D. Urdal, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Correlation between product parameters and overall survival in three trials of sipuleucel-T, an autologous active cellular immunotherapy for the treatment of prostate cancer.

D. McNeel, M. Frohlich, N. Sheikh, 2010 .

The treatment of induced immune deficiency with interleukin-2.

C. Henney, P. Conlon, S. Gillis, 1985, Immunology letters.

Characterization of the cell surface receptor for a multi-lineage colony-stimulating factor (CSF-2 alpha).

D. Friend, L. Park, S. Gillis, 1986, The Journal of biological chemistry.

Molecular Characterization of Colony‐ Stimulating Factors and Their Receptors: Human Interleukin‐3

V. Price, D. Cosman, L. Park, 1989, Annals of the New York Academy of Sciences.

The effects in vivo of purified preparations of murine macrophage colony stimulating factor-1, recombinant murine granulocyte-macrophage colony stimulating factor and natural and recombinant murine interleukin 3 without and with pretreatment of mice with purified iron-saturated human lactoferrin.

D. Williams, A. Waheed, H. Boswell, 1986, Immunobiology.

Interactions between purified murine colony-stimulating factors (natural CSF-1, recombinant GM-CSF, and recombinant IL-3) on the in vitro proliferation of purified murine granulocyte-macrophage progenitor cells.

D. Williams, H. Broxmeyer, A. Waheed, 1987, Experimental hematology.

Human macrophage colony stimulating factor (M-CSF): alternate RNA splicing generates three different proteins that are expressed on the cell surface and secreted.

D. Cerretti, D. Cosman, B. Gallis, 1988, Behring Institute Mitteilungen.

In vitro and in vivo cytokine-induced facilitation of immunohematopoietic reconstitution in mice undergoing bone marrow transplantation.

A. Landesberg, E. Kedar, S. Slavin, 1988, Bone marrow transplantation.

Phosphorylation of the human interleukin-2 receptor and a synthetic peptide identical to its C-terminal, cytoplasmic domain.

T. Hopp, D. Cosman, B. Gallis, 1986, The Journal of biological chemistry.

Production of recombinant human colony stimulating factors in yeast.

V. Price, D. Cosman, S. Gillis, 1988, Behring Institute Mitteilungen.

Lymphokines: from conjecture to the clinic.

T. Hopp, V. Price, D. Cosman, 1986, Seminars in oncology.

The Interleukin- 1 Receptor Binds the Human Interleukin- la! Precursor but Not the Interleukin- 1@ Precursor*

Gillis, S. Dower, Steven, 2001 .

Characterization of the cell surface receptor for human granulocyte/macrophage colony-stimulating factor

D. Friend, L. Park, S. Gillis, 1986, The Journal of experimental medicine.

Heterogeneity in Human Interleukin-3 Receptors

D. Friend, V. Price, L. Park, 2001 .

Abstract 5608: Sipuleucel-T treatment results in sequentialex vivoactivation of APCs and T cells during the culture step - evidence forin vivoimmunological priming

M. Frohlich, N. Sheikh, D. Urdal, 2010 .

Hematopoietic growth-factor receptors.

L. Park, S. Gillis, D. Urdal, 1990, Immunology series.